MEDI0457 Plus Durvalumab in HPV-associated HNSCC-Response
- PMID: 37449358
- DOI: 10.1158/1078-0432.CCR-23-1057
MEDI0457 Plus Durvalumab in HPV-associated HNSCC-Response
Comment on
-
MEDI0457 Plus Durvalumab in HPV-associated HNSCC-Letter.Clin Cancer Res. 2023 Jul 14;29(14):2735. doi: 10.1158/1078-0432.CCR-23-0895. Clin Cancer Res. 2023. PMID: 37449359 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
